Tech & AI
FDA orders vision-loss warning on GLP-1 drug labels
Ars Technica, the agency's drug safety communication, issued on a Monday, names Ozempic, Wegovy, Zepbound and Mounjaro and describes a "potential increased risk" of a rare eye condition that can lead
Benjamin Scott2 min read
